29 June, 2014


Hi folks,

Hope you all are doing well. After a break of 6 weeks from blogging I am back......!

So let’s start with good news!

There might be chance that out patients can use insulin without pricks!


FDA has approved Oral insulin for clinical use. It’s named AFREZZA (uh-FREZZ-uh)

AFREZZA is insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus.

AFREZZA is not for use in place of long-acting insulin. AFREZZA must be used with long-acting insulin in people who have type 1 diabetes mellitus.

 AFREZZA is not for use to treat diabetic ketoacidosis.

It is not known if AFREZZA is safe and effective for use in people who smoke. AFREZZA is not for use in people who smoke or have recently stopped smoking(less than 6 months)

It is not known if AFREZZA is safe and effective in children under 18 years of age

This drug comes in a form of inhaler with cartridges of 4units and 8 units.

This is how it looks!
We hope this product will be in India soon.

One main side effect is that it can reduce lung function. Some of them also have mentioned about incidences of lung cancer but these side effect profile needs to be confirmed. This drug will be ideal if the side effects mentioned are not because of AFREZZA.

Will update as soon as I get more info on this product.

Dr.Riyaz Sheriff
R.S Clinic
165/3B Teacher's colony
Chennai 600115